The effects of recombinant human growth hormone therapy on thyroid function in pediatric patients with growth hormone deficiency

BACKGROUND: Recombinant human growth hormone (rhGH) was approved for the therapy of pediatric patients with growth hormone deficiency (GHD) by the Food and Drug Administration (FDA) of the United States in 1985. This study aims to evaluate the effects of rhGH therapy on thyroid function in pediatric...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Transl Pediatr
Main Authors: Yao, Qian, Zheng, Dong, Liang, Yan, Hou, Ling, Ying, Yan-Qin, Luo, Xiao-Ping, Wu, Wei
Formato: Artigo
Idioma:Inglês
Publicado: AME Publishing Company 2021
Assuntos:
Original Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC8107847/
https://ncbi.nlm.nih.gov/pubmed/34012834
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21037/tp-20-401
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares